Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Wells Pharma of Houston LLC recalls fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
cGMP deviations.
Products
  • fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride
Where it was sold

U.S. Nationwide.

Nationwide

Units affected
50 syringes
About this recall
fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.